Motivations for opioid and stimulant use among drug using black sexual minority men: A life course perspective.
Where this comes from
- Record sourced from PubMed, PMID 32777690.
- Also identified by DOI 10.1016/j.drugalcdep.2020.108224 and PMC identifier 7502465.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
HIV-related disparities persist among U.S. Black sexual minority men (BSMM). Generational differences in drug use trends and the HIV/AIDS epidemic have created different risk trajectories for BSMM. This study explored age-related differences in the profiles, motivations, and contexts of opioid and stimulant use among drug using BSMM. Participants were recruited using active and passive strategies and in-depth qualitative interviews were conducted among 30 BSMM in Baltimore, MD from December 2018 to March 2019. Exploratory drug testing was conducted to confirm drug use and identify the presence of synthetic materials. Thematic analysis was conducted guided by Life Course theoretical domains. Participants' ages ranged from 25-63 (mean age 41, SD = 12.4); 40 % were under age 35, 60 % were age 35 and older. Most (86.7 %) were living with HIV. Older BSMM attributed drug use initiation to social trends and sexual partners; younger men shared that prescription painkiller use led to misuse to address emotional pain. Across age groups, childhood sexual abuse and other major events along the life course increased BSMM's drug use as a coping strategy. HIV and drug use interventions should support BSMM through targeted mental health services and trauma-informed healthcare models.
Medical subject headings
- Analgesics, Opioid
- Central Nervous System Stimulants
- Sexual and Gender Minorities
- Substance-Related Disorders